The emerging treatment of the medication represents a exciting advance in the care of type 2 diabetes. Different to existing therapies, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatidepeptide422429.ampedpages.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-69120606